The Anti-Kickback Statute should be broadly interpreted as a bar to any kind of payment in exchange for health care services paid for by the government, the U.S. Attorney’s Office in Philadelphia argued in a qui tam suit brought against a pharmaceutical company called Allergan.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.